TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies.

G A Cirkel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.